#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Ischaemic stroke Glomerulonephritis chronic Immune thrombocytopenia Non-Hodgkin's lymphoma unspecified histology aggressive recurrent Loeys-Dietz syndrome Thrombocytopenia Pyoderma gangrenosum Cognitive disorder Neurodegenerative disorder Glioblastoma Piriformis syndrome Progressive supranuclear palsy Dementia with Lewy bodies Necrotising enterocolitis neonatal Infantile spasms More trials…

    Learn about Rare Diseases

    Glycogen storage disease type V – Basic Information Activated PI3 kinase delta syndrome Hereditary angioedema with C1 esterase inhibitor deficiency Proteus syndrome Pulmonary fibrosis Hereditary hypophosphataemic rickets – Trials in Disease Encephalitis autoimmune – Life with Disease Nephrotic syndrome – Life with Disease CADASIL – Trials in Disease Idiopathic pulmonary fibrosis More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Boserolimab Autologous Pancreatic Islets AUR200 Regn9933 Anhydrous Glucose Bp Odm-111 Fulvestrant SKB410 Montelukast Sodium Vibosameran Lorazepam Pantoprazole Hydrocortisone Ph. Eur. SODIUM SELENITE PENTAHYDRATE Burfiralimab VAMIFEPORT TRIHYDROCHLORIDE Msv-Allo Riboflavin Sodium Phosphate Estriol Buprenorphine More therapies…

    Learn about Your Condition

    Dystonia Hepatitis D Psoriasis Schizoaffective disorder Breast cancer in situ Seasonal allergy Renal cell carcinoma Polycystic ovarian syndrome Ophthalmoplegia Muscle strain Radiation skin injury Craniotomy Chronic myeloid leukaemia Macular telangiectasia Abdominal pain More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Barrett’s oesophagus

  • Study on the Safety and Feasibility of Bevacizumab-800CW Imaging for Patients with Barrett’s Esophagus, Colon Cancer, or Gastrointestinal Dysplasia

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Barrett’s oesophagus
    • Colon cancer
    Investigated Drugs:
    • Bevacizumab
    The Netherlands
  • Study on Budesonide Tablets for Preventing Esophageal Narrowing in Adults After Cancer Tissue Removal

    Not recruiting

    2 1
    Investigated Diseases:
    • Barrett’s oesophagus
    • Oesophageal squamous cell carcinoma
    • Oesophageal adenocarcinoma
    Investigated Drugs:
    • Budesonide
    France Germany The Netherlands Poland Portugal Spain +1
  • Study on Detecting Early Barrett’s Esophagus Using Bevacizumab-800CW and Cetuximab-800CW for Patients with Barrett’s Esophagus

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Barrett’s oesophagus
    Investigated Drugs:
    • Bevacizumab
    • Cetuximab
    The Netherlands

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.


European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!